TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage of Participants With Satisfied or Very Satisfied on Item #1 for the CSQ
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Numbers of Participants With Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of burnout symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants achieving LDL-C target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clarity of the arthroscopic surgical field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: postoperative pain during rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: additional analgesics consumption post-operatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Global Progression Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Score on the Perceived Stress Scale (PSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Gestational Age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First diagnosis of TB
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants with First Invasive Extraintestinal Pathogenic E.coli Disease Event
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with treatment-emergent adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Standard deviation of CT attenuation values at the liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported trust in Instagram content
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CSF culture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: normalization of the CSF chemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of probiotic and zinc supplementation
Endpoint domain: Adverse events/effects
Primary endpoint: Blood concentration of PB and taurursodiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic exposure to PB and taurursodiol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in physical activity participation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adverse Event Monitoring
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Plasma Concentration of HGR4113
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve of HGR4113 Over Dosing Interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6 Month Progression-Free Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Cystometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity index scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of the HistoSonics Edison System
Endpoint domain: Adverse events/effects
Primary endpoint: any stroke (ischemic or hemorrhagic) or death
Endpoint domain: Mortality/survival
Primary endpoint: Time to first composite cardiovascular endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: patients' satisfaction with professional care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hemagglutinin antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neuraminidase antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Knowledge on Physiotherapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Benefits of Physiotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Collaboration between healthcare professionals
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Resting State fMRI Functional Connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOLD Percent Signal Change Under Conditions of Visual Stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the viral load-time curve (VL-AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change from baseline Anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants achieving WP-NRS reduction ≥ 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nuclear factor erythroid 2-related factor 2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TUNEL Staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mason's Trichrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Tissue and organ outcomes
Primary endpoint: Intra-abdominal recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of patients with at least one adverse device effect (ADE)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in total Active Listening Attitude Scale (ALAS) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Tendon Cross-Sectional Area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bone turnover markers (CTx + P1NP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Abnormal Involuntary Movement Scale (AIMS) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eTICI 2b-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in state mindfulness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants who Experience a Dose-limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Change in gut microbiota composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean score of the Newborn Infants Pain Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportions of digital tool use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Severity of Cannabis Use Disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Dependence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Inhibitory Control
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Short-term response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Network identification with MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognosis of network targeting with surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Interest of adding epileptic network radiological analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hazard Ratio of Subsequent peritonitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Plasma new antibiotics concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Calculated clearances of new antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of sleep disorders in patients with FMS
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Prevalence of sleep apnea syndrome in patients with FMS
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Prevalence of restless legs syndrome in patients with FMS
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage change in LDL-C from baseline at 12 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage change in MRI-PDFF from baseline at 12 week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle strength in isokinetic
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Need for hospitalization for AECOP
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Identification of Inflammatory Biomarkers (BAFF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Identification of Glycation Biomarkers (MGO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to intervention practices
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: relative ADAMTS13 deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in the Motor Function Measure (MFM32)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the Peak Inspiratory Pressure (PIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in the Peak Expiratory Pressure (PEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pyloric distensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Self-Reported Physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Objectively measured Physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Complications of SLE patients
Endpoint domain: Adverse events/effects
Primary endpoint: Change in sputum weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Root canal treatment success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dialysis Symptom Index (DSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of readmission at 12 months
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Diameter stenosis rate of bifurcation lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Maximum standardized uptake value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete common bile stone clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oswestry Low Back Pain Disability Questionnaire (OLBPDQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Electrocardiogram and holter monitor data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hepatic Perfusion Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: COVID-19 related Hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: COVID-19 related all-caused mortality
Endpoint domain: Mortality/survival
Primary endpoint: 6 Minute Pegboard and Ring Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Implementation Success
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of subjects with complete ovarian inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change from baseline in Patient Global Impression of Change (PGIC) scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peak hamstring torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak quadriceps torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak hip abductor torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression levels of clock genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall clinical clearance rate of skin lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blood culture diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Self-Efficacy - Competence Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Decision Making Scale in Nursing
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Total adverse event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of dressing replacement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recurrent abortion
Endpoint domain: Mortality/survival
Primary endpoint: Change in ESS Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AI stenosis reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Agatston scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EAT analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of successful completion of prehabilitation program
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: seizure reduction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increased number of DR patients for eye screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Validation of MARIA breast classifier for malignant/benign tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Distance between LCA and IMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance from LCA to IMA and IMV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychedelic-Assisted Therapist Self-Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Short form survey (SF-12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Hamilton Depression Rating Scale (HAM-D)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Revised urinary incontinence scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Fasting lipid profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Participants with At Least One Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma Concentration of GDC-8264
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gamma synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Digital Blood Flow Based on Rewarming AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Digital Blood Flow Based on Reperfusion AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of echocardiography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability at RP2D of CPO301
Endpoint domain: Adverse events/effects
Primary endpoint: Root mean square error of the knee flexion angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symmetry ratio of the stance phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of intestinal ultrasound for pouchitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Incidence of Malignancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cumulated pain during walking days 2-7
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Numeric Pain Rating Scale changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Specific Functional Scale changes
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Swanson, Nolan, and Pelham IV Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline Minute Ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilatory Recruitment Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Slope of the PCO2-ventilatory Response Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Extrapolated Ventilatory Recruitment Threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Migraine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Tension Headache
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Absolute Lymphocyte Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of ED Visits or Inpatient Hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mindful Breastfeeding Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breast Feeding Adaptation Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postpartum Breastfeeding Self-Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of study-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of anti-TB DILI
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mu modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of major wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma NGAL Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Renal Doppler Resistive Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: baseline height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline body mass index (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline urea & electrolytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: baseline liver function test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence rate of primary diagnosis of pancreatic cancer
Endpoint domain: Mortality/survival
Primary endpoint: Hazard ratio of primary diagnosis of pancreatic cancer
Endpoint domain: Mortality/survival
Primary endpoint: Maximum Tolerated Dose of M28z1XXPD1DNR CAR T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in visuomotor coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in speed and accuracy of movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in bimanual coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast Cancer Awareness Measure Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maternal childbirth self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neurocognition Index (NCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of Participants Who Follow Up With Recommended Eye Care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: stoma-free survival at two years
Endpoint domain: Mortality/survival
Primary endpoint: OSDI Dry Eye Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vision Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K5 (Non-Invasive Tear Break-Up Time (NITBUT))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent thrombosis occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Gastrointestinal (GI) Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Death, Serious Adverse Event(s), AEs and Treatment Emergent Adverse Events (TEAEs)
Endpoint domain: Adverse events/effects